Sandoz Bisoprololo 2.5 mg

Bisoprololo Sandoz is a generic pharmaceutical product used primarily for treating hypertension and cardiac conditions. The brand Sandoz has a deep-rooted history in the pharmaceutical industry, originating in Basel, Switzerland, in 1886. For many years, Sandoz was a core division of the Swiss multinational Novartis.

Following a strategic shift in 2023, Sandoz was successfully spun off from Novartis to become an independent, publicly traded company. It is now a global leader in generic and biosimilar medicines. While the company is headquartered in Switzerland, its manufacturing network is extensive, with production facilities located across Europe (including Austria, Germany, and Slovenia) and globally to serve international markets.